Home Contact Center Add this

Debiopharm Research & Manufacturing S.A.

The Company is a world leader in polylactic-co-glycolic acid (PLGA)-based injectable, sustained-release technology. It has been used for one of our best-selling product Decapeptyl®, a novel injectable controlled-release formulation of triptorelin - a gonadotropin releasing hormone (GnRH) agonist analogue. This mode of administration developed by Debio R.P. relies on the active substance being "encapsulated" in a PLGA polymer to allow gradual dissolution and distribution of the substance in the patient's body.

The Company has succeeded in producing

  • 1-month,
  • 3-month and
  • 6-month sustained-release (SR) formulations.

It is also focusing on nanoparticular drug delivery systems.

Cédric Sager

Cédric Sager

Chief Executive Officer, Debiopharm Research & Manufacturing S.A.

Dr Sager received his Diploma of Chemist from the University of Lausanne in 1996 and then obtained his Ph.D. in Peptide Chemistry, in 2001. He joined Debiopharm Research & Manufacturing in 2001 as QC Engineer. In 2004, he became Manufacturing Director, taking over the responsibility of the production. In 2011, Dr Sager took the Direction of Operations of Debiopharm Research & Manufacturing SA and he became CEO in 2012.

Marie-Anne Bardet

Marie-Anne Bardet

Project Management & Scientific Director, Debiopharm Research & Manufacturing S.A.

Dr Bardet received her Diploma of Chemist from the University of Paris VI in 1990 and then obtained her Ph.D. in Environmental Chemistry and Health, from the University of Aix Marseille I in 1994. She joined Debiopharm Research & Manufacturing SA in 2001 as Chemist in the Analytical Development department. Then she held different positions in the Pharmaceutical Development department. In 2010, she was appointed Project Management & Scientific Director.

Anne Marguerettaz

Anne Marguerettaz

Regulatory, Optimization and Industrialisation Director, Debiopharm Research & Manufacturing S.A.

Dr Marguerettaz received a Bachelor of Science in Chemistry in 1987 and a Ph.D. in Protein Chemistry in 1993 from Carnegie Mellon University, Pittsburgh (PA). She joined Debiopharm International SA in 1998 as Development & Process of API Manager. In 2001 she became Biotech API Contract Manufacturing Manager. She took over the responsibility of Debiopharm Research & Manufacturing’s Quality Control as QC Director in 2005, and she became Regulatory, Optimization and Industrialisation Director in 2011.

Yves Galy

Yves Galy

Logistics & Strategic Planning Director, Debiopharm Research & Manufacturing S.A.

Dr Galy received his Diploma of Industrial Pharmacy from the University of Lyon and obtained his Ph.D. in Pharmaceutical Sciences and DESS quality, in 1991. He later specialised in Forensic science in Paris V - 1995. He joined Debiopharm Research & Manufacturing SA in 1998, first as Operations Manager and as of 2000 as Director of Manufacturing Operations. In August 2005, he took over his current responsibilities as Logistics & Strategic Planning Director.

Patrick Garrouste

Patrick Garrouste

Drug Research & Development Director, Debiopharm Research & Manufacturing S.A.

Dr Garrouste completed his M.Sc. in Biochemistry and his Ph.D. in Bioorganic Chemistry at the Université des Sciences et Techniques du Languedoc (USTL) in Montpellier, France (1995). He then joined the Institute of Organic Chemistry, Lausanne, Switzerland, where he was First assistant from 1995 to 1998. In 1998, he joined the Pharmaceutical Development Department at Debiopharm Research & Manufacturing SA. He held first a position of Analytical Development Assistant followed by a position of Head of Analytical Development (2001). In 2004, he took over the responsibility of the department as Drug Research & Development Director.

Marco Salvagni

Marco Salvagni

Director of Operations, Debiopharm Research & Manufacturing S.A.

Mr. Salvagni received his Chemical Engineering Diploma from the "Ecole d'Ingénieurs de Genève" (E.I.G.) in 1999. He recently obtained an Executive MBA in MoT (Management of Technology) from the EPFL in 2015. He acquired a broad experience essentially in R&D and production at OM Pharma and Vifor Pharma in Geneva. He then joined Debiopharm Research & Manufacturing SA on April 1st 2015 as Director of Operations.

Vincent Griffoul

Vincent Griffoul

Industrial Opportunities Director, Debiopharm Research & Manufacturing S.A.

Dr Griffoul received his Ph.D. in Pharmaceutical Sciences, DEA-Biopharmacy and galenical research from the University of Paris XI in 1980. He obtained an MBA from the University of Strasbourg Schiller in 1993. He joined Debiopharm Research & Manufacturing SA in 2006 as Process Improvement Director and in 2007 became Technical Services Director as well. In 2016, he has been nominated as Industrial Opportunities Director.

Olivier Imboden

Olivier Imboden

Administration & HR Director, Debiopharm Research & Manufacturing S.A.

Mr. Imboden received his Master Degree in Social Sciences from the University of Lausanne in 1999. He achieved a «Brevet Fédéral de Spécialiste en Gestion des Ressources Humaines» in 2004. He joined Debiopharm Research & Manufacturing in 2001 as HR collaborator. In 2002 he became HR Manager and in 2004 he took over the responsibility of the administration department as Administration & HR Director.

Moreno Centelleghe

Moreno Centelleghe

Technical Service Director, Debiopharm Research & Manufacturing S.A.

Mr. Centelleghe obtained his BS Mechanical Engineering in 1991. He achieved his Safety Engineering Diploma in 2003 and holds an MBA from Geneva University in 2005. Mr. Centelleghe has acquired a broad experience in the pharmaceutical and chemical industry including maintenance, engineering, facilities and EHS functions at ORGAMOL and BASF Companies. He joined Debiopharm Research & Manufacturing S.A. in 2016 as Director of Technical Service.

Thanh Liem Vu

Thanh Liem Vu

Quality Assurance Director, Debiopharm Research & Manufacturing S.A.

Dr Vu received his Diploma of Pharmacy from the School of Pharmacy of Lausanne University, Switzerland in 1994 and then obtained his Ph.D. in Pharmaceutical Sciences in 1999. He gained a broad experience in Pharmaceutical Industry including Quality Assurance, Validation and Manufacturing activities at UCB farchim SA and Vifor SA. He joined Debiopharm International SA in 2008 as Pharmaceutical QA Manager/Qualified Person. Since 2010, Dr Vu has been heading Debiopharm Research & Manufacturing's Quality Assurance Department and acting as Qualified Person for Debiopharm Group. In 2012, he joined the Executive Board of Directors of Debiopharm Research & Manufacturing SA.

Debiopharm Research & Manufacturing S.A.

(formerly Debio R.P. SA)
Campus “après-demain”
Rue du Levant 146
1920 Martigny
Switzerland

Tel. +41 (0)27 721 7900
Fax +41 (0)27 721 7901